This is the first FDA approved medication for the rare and progressive neurodegenerative disease, Niemann-Pick Disease Type C ...

GeneCQ uses integrated medical and pharmacy claims data to provide insight into the exposure to the costs for gene therapies.

Bimzelx was first approved last year for the treatment of moderate to severe psoriasis in adults, making it the first and ...

Results looking at the first season of RSV use shows that it is 75% effective at preventing RSV-associated hospitalizations ...

New anecdotal evidence suggests some chemoimmunotherapy treatments may improve pulmonary arterial hypertension symptoms, but the overall evidence remains murky.

Pediatric patients are also more susceptible to becoming addicted to ketamine and forming substance abuse disorders.

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

Respondents predict that the highest rates will be reflected in all outpatient prescription drugs with an 11.4% increase, up ...

Three different doses of Niktimvo all had high rates of response among patients with recurrent or refractory ...

Children with spinal muscular atrophy (SMA) experience benefits from receiving a disease-modifying gene therapy, but many ...

Today’s approval means that FluMist is the first pharmacy-prescribed influenza vaccine that does not need to be given by a ...

Whether Express Scripts wins its unique defamation lawsuit will depend on whether the PBM can prove the FTC made false ...